123 related articles for article (PubMed ID: 33854299)
1. Erratum: Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study [Corrigendum].
Drug Des Devel Ther; 2021; 15():1477. PubMed ID: 33854299
[TBL] [Abstract][Full Text] [Related]
2. Erratum: Efficacy and Safety of a Subanesthetic Dose of Esketamine Combined with Propofol in Patients with Obesity Undergoing Painless Gastroscopy: A Prospective, Double-Blind, Randomized Controlled Trial [Corrigendum].
Drug Des Devel Ther; 2023; 17():3231-3232. PubMed ID: 37936963
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study.
Hong SJ; Sung KC; Lim SW; Kim SY; Kim W; Shin J; Park S; Kim HY; Rhee MY;
Drug Des Devel Ther; 2020; 14():5735-5746. PubMed ID: 33408462
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
Volpe M; Christian Rump L; Ammentorp B; Laeis P
Clin Drug Investig; 2012 Oct; 32(10):649-64. PubMed ID: 22909147
[TBL] [Abstract][Full Text] [Related]
5. Erratum: Efficacy and Safety of Retinol Palmitate Ophthalmic Solution in the Treatment of Dry Eye: A Japanese Phase II Clinical Trial [Corrigendum].
Drug Des Devel Ther; 2021; 15():813-816. PubMed ID: 33658762
[TBL] [Abstract][Full Text] [Related]
6. Erratum: Fatostatin in Combination with Tamoxifen Induces Synergistic Inhibition in ER-Positive Breast Cancer [Corrigendum].
Drug Des Devel Ther; 2022; 16():1-2. PubMed ID: 35023901
[TBL] [Abstract][Full Text] [Related]
7. Erratum: Zafirlukast in Combination with Pseudohypericin Attenuates Spinal Cord Injury and Motor Function in Experimental Mice [Corrigendum].
Drug Des Devel Ther; 2021; 15():419-422. PubMed ID: 33603335
[TBL] [Abstract][Full Text] [Related]
8. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
[TBL] [Abstract][Full Text] [Related]
9. Erratum: Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial [Corrigendum].
Drug Des Devel Ther; 2022; 16():2681-2682. PubMed ID: 35978858
[TBL] [Abstract][Full Text] [Related]
10. Erratum: Attenuation of Myocardial Fibrosis with Curcumin Is Mediated by Modulating Expression of Angiotensin II AT1/AT2 Receptors and ACE2 in Rats [Corrigendum].
Drug Des Devel Ther; 2020; 14():2515. PubMed ID: 32636613
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial [Corrigendum].
Drug Des Devel Ther; 2023; 17():3033-3034. PubMed ID: 37789967
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Minoxidil and Its Use in Hair Disorders: A Review [Corrigendum].
Drug Des Devel Ther; 2020; 14():575. PubMed ID: 32103899
[TBL] [Abstract][Full Text] [Related]
13. Erratum: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain [Corrigendum].
Clin Pharmacol; 2023; 15():63-65. PubMed ID: 37397409
[TBL] [Abstract][Full Text] [Related]
14. Erratum: Galangin Improved Non-Alcoholic Fatty Liver Disease in Mice by Promoting Autophagy [Corrigendum].
Drug Des Devel Ther; 2021; 15():231. PubMed ID: 33505157
[TBL] [Abstract][Full Text] [Related]
15. Erratum: In situ Delivery of Thermosensitive Gel-Mediated 5-Fluorouracil Microemulsion for the Treatment of Colorectal Cancer [Corrigendum].
Drug Des Devel Ther; 2020; 14():2125-2126. PubMed ID: 32581512
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Ursolic Acid Reduces the Metalloprotease/Anti-Metalloprotease Imbalance in Cerebral Ischemia and Reperfusion Injury [Corrigendum].
Drug Des Devel Ther; 2021; 15():2483-2484. PubMed ID: 34149284
[TBL] [Abstract][Full Text] [Related]
17. Erratum: Effect of Lactoferrin Protein on Red Blood Cells and Macrophages: Mechanism of Parasite-Host Interaction [Corrigendum].
Drug Des Devel Ther; 2020; 14():2123-2124. PubMed ID: 32581511
[TBL] [Abstract][Full Text] [Related]
18. Erratum: A Novel Hybrid Compound LLP2A-Alendronate Accelerates Open Fracture Healing in a Rabbit Model [Corrigendum].
Drug Des Devel Ther; 2019; 13():4159-4160. PubMed ID: 31849447
[TBL] [Abstract][Full Text] [Related]
19. Erratum: The Steady-State Comparative Bioavailability of Intramuscular Risperidone ISM and Oral Risperidone: An Open-Label, One-Sequence Study [Corrigendum].
Drug Des Devel Ther; 2022; 16():1791-1792. PubMed ID: 35719214
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Hydroxyapatite Nanoparticles Facilitate Osteoblast Differentiation and Bone Formation Within Sagittal Suture During Expansion in Rats [Corrigendum].
Drug Des Devel Ther; 2021; 15():3617-3618. PubMed ID: 34447242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
